Breast Cancer Risk Reduction Decisions of the BRCA-Positive Patient: An Observational Study at a Single Institution

D Johns, J Agarwal, L Anderson, J Ying… - Journal of Women's …, 2017 - liebertpub.com
Background: BRCA1 and BRCA2 gene mutations carry with them a 50%–80% risk of
developing breast cancer. The best choice for managing breast cancer risk in patients with a …

Breast Cancer Risk Reduction Decisions of the BRCA-Positive Patient: An Observational Study at a Single Institution

D Johns, J Agarwal, L Anderson… - Journal of women's …, 2017 - pubmed.ncbi.nlm.nih.gov
Background BRCA1 and BRCA2 gene mutations carry with them a 50%-80% risk of
developing breast cancer. The best choice for managing breast cancer risk in patients with a …

Breast cancer risk reduction decisions of the BRCA-positive patient: an observational study at a single institution.

D Johns, J Agarwal, L Anderson, YJ Ying Jian… - 2017 - cabidigitallibrary.org
Background: BRCA1 and BRCA2 gene mutations carry with them a 50%-80% risk of
developing breast cancer. The best choice for managing breast cancer risk in patients with a …

Breast Cancer Risk Reduction Decisions of the BRCA-Positive Patient: An Observational Study at a Single Institution.

D Johns, J Agarwal, L Anderson, J Ying… - Journal of Women's …, 2016 - europepmc.org
Background BRCA1 and BRCA2 gene mutations carry with them a 50%-80% risk of
developing breast cancer. The best choice for managing breast cancer risk in patients with a …

Breast Cancer Risk Reduction Decisions of the BRCA-Positive Patient: An Observational Study at a Single Institution.

D Johns, J Agarwal, L Anderson… - Journal of Women's …, 2017 - search.ebscohost.com
Background: BRCA1 and BRCA2 gene mutations carry with them a 50%-80% risk of
developing breast cancer. The best choice for managing breast cancer risk in patients with a …